重症患者谵妄管理专家共识

2019-02-20 国内急诊/重症相关专家小组(统称) 中华内科杂志.2019,58(2):108-118.

谵妄是ICU中常见的一种急性临床综合征,可导致患者病死率增加,机械通气时间和住院时间延长,引起长期的认知功能障碍,增加医疗费用,严重影响患者的预后。为规范重症患者的谵妄管理,由中国冷静治疗研究组根据国内外最新文献资料和多年来的应用推广经验,组织相关重症医学专家在充分讨论和沟通基础上制定了“重症患者谵妄管理专家共识”。旨在改进重症患者的谵妄管理,优化镇痛镇静治疗,改善患者的预后。拓展指南:与谵妄相关

中文标题:

重症患者谵妄管理专家共识

发布日期:

2019-02-20

简要介绍:

谵妄是ICU中常见的一种急性临床综合征,可导致患者病死率增加,机械通气时间和住院时间延长,引起长期的认知功能障碍,增加医疗费用,严重影响患者的预后。为规范重症患者的谵妄管理,由中国冷静治疗研究组根据国内外最新文献资料和多年来的应用推广经验,组织相关重症医学专家在充分讨论和沟通基础上制定了“重症患者谵妄管理专家共识”。旨在改进重症患者的谵妄管理,优化镇痛镇静治疗,改善患者的预后。

拓展指南:与谵妄相关指南:
更多信息请点击:与谵妄更多指南

相关资料下载:
[AttachmentFileName(sort=100, fileName=重症患者谵妄管理专家共识)] GetToolGuiderByIdResponse(projectId=1, id=108841c001e666e0, title=重症患者谵妄管理专家共识, enTitle=, guiderFrom=中华内科杂志.2019,58(2):108-118., authorId=null, author=, summary=谵妄是ICU中常见的一种急性临床综合征,可导致患者病死率增加,机械通气时间和住院时间延长,引起长期的认知功能障碍,增加医疗费用,严重影响患者的预后。为规范重症患者的谵妄管理,由中国冷静治疗研究组根据国内外最新文献资料和多年来的应用推广经验,组织相关重症医学专家在充分讨论和沟通基础上制定了“重症患者谵妄管理专家共识”。旨在改进重症患者的谵妄管理,优化镇痛镇静治疗,改善患者的预后。拓展指南:与谵妄相关, cover=, journalId=null, articlesId=null, associationId=780, associationName=国内急诊/重症相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Wed Feb 20 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>谵妄是ICU中常见的一种急性临床综合征,可导致患者病死率增加,机械通气时间和住院时间延长,引起长期的认知功能障碍,增加医疗费用,严重影响患者的预后。为规范重症患者的谵妄管理,由中国冷静治疗研究组根据国内外最新文献资料和多年来的应用推广经验,组织相关重症医学专家在充分讨论和沟通基础上制定了“重症患者谵妄管理专家共识”。旨在改进重症患者的谵妄管理,优化镇痛镇静治疗,改善患者的预后。</div><div><br></div><div>拓展指南:与<span style="color: rgb(255, 0, 0);">谵妄</span>相关指南:</div><div><a href="http://www.medsci.cn/guideline/show_article.do?id=2ffa91c00163020d">2018 SCCM临床实践指南:ICU内成人患者疼痛,躁动/镇静,谵妄,固定以及睡眠中断的管理</a></div><div><a href="http://www.medsci.cn/guideline/show_article.do?id=4e9091c00161591d">2018 ESMO临床实践指南:成人癌症患者谵妄的管理</a></div><div><a href="http://www.medsci.cn/guideline/show_article.do?id=f24181c001ae7841">老年患者术后谵妄防治中国专家共识</a></div><div><a href="http://www.medsci.cn/guideline/show_article.do?id=aef7c1c0013592a1">2017 ESA循证共识指南:术后谵妄</a></div><div><a href="http://www.medsci.cn/guideline/show_article.do?id=d97d11c0011336af">2014 AGS临床实践指南:老年患者术后谵妄(摘要)</a></div><div>更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%B0%B5%E5%A6%84">与谵妄更多指南</a></div><div><br></div>, tagList=[TagDto(tagId=4762, tagName=谵妄), TagDto(tagId=12126, tagName=重症)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5497, appHits=524, showAppHits=31, pcHits=2364, showPcHits=4267, likes=77, shares=40, comments=21, approvalStatus=1, publishedTime=Fri Jul 26 14:46:48 CST 2019, publishedTimeString=2019-02-20, pcVisible=1, appVisible=1, editorId=5296068, editor=qi.yuan, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qi.yuan, createdTime=Fri Jul 26 14:46:48 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 15:20:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=重症患者谵妄管理专家共识)])
重症患者谵妄管理专家共识
下载请点击:
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2141180, encodeId=c6842141180e0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75415234, createdName=ms6000000204662260, createdTime=Tue Jun 06 23:59:40 CST 2023, time=2023-06-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1201732, encodeId=bbe71201e3257, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed35625050, createdName=ms4000000919175717, createdTime=Fri Mar 11 16:26:59 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200829, encodeId=5cb3120082985, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/10/9c891de22a04ad3664335f140cf03e65.jpg, createdBy=98035075733, createdName=145a16f4m24暂无昵称, createdTime=Wed Mar 09 10:18:04 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193337, encodeId=2b3b119333e10, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b55675ktMWicxZps0b0Tt21jZhnAsy86ntv7Od1ldhicQL19tWMG4xq1EicYN1jBKhe73qYKib6aQkrFsL3pEZFASw/132, createdBy=50e92381638, createdName=Aling 陶宇满玲, createdTime=Mon Feb 14 16:47:58 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064946, encodeId=37c91064946f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dd32880781, createdName=jy21354, createdTime=Fri Oct 29 12:11:52 CST 2021, time=2021-10-29, status=1, ipAttribution=)]
    2023-06-06 ms6000000204662260 来自江苏省

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2141180, encodeId=c6842141180e0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75415234, createdName=ms6000000204662260, createdTime=Tue Jun 06 23:59:40 CST 2023, time=2023-06-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1201732, encodeId=bbe71201e3257, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed35625050, createdName=ms4000000919175717, createdTime=Fri Mar 11 16:26:59 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200829, encodeId=5cb3120082985, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/10/9c891de22a04ad3664335f140cf03e65.jpg, createdBy=98035075733, createdName=145a16f4m24暂无昵称, createdTime=Wed Mar 09 10:18:04 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193337, encodeId=2b3b119333e10, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b55675ktMWicxZps0b0Tt21jZhnAsy86ntv7Od1ldhicQL19tWMG4xq1EicYN1jBKhe73qYKib6aQkrFsL3pEZFASw/132, createdBy=50e92381638, createdName=Aling 陶宇满玲, createdTime=Mon Feb 14 16:47:58 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064946, encodeId=37c91064946f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dd32880781, createdName=jy21354, createdTime=Fri Oct 29 12:11:52 CST 2021, time=2021-10-29, status=1, ipAttribution=)]
    2022-03-11 ms4000000919175717

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2141180, encodeId=c6842141180e0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75415234, createdName=ms6000000204662260, createdTime=Tue Jun 06 23:59:40 CST 2023, time=2023-06-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1201732, encodeId=bbe71201e3257, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed35625050, createdName=ms4000000919175717, createdTime=Fri Mar 11 16:26:59 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200829, encodeId=5cb3120082985, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/10/9c891de22a04ad3664335f140cf03e65.jpg, createdBy=98035075733, createdName=145a16f4m24暂无昵称, createdTime=Wed Mar 09 10:18:04 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193337, encodeId=2b3b119333e10, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b55675ktMWicxZps0b0Tt21jZhnAsy86ntv7Od1ldhicQL19tWMG4xq1EicYN1jBKhe73qYKib6aQkrFsL3pEZFASw/132, createdBy=50e92381638, createdName=Aling 陶宇满玲, createdTime=Mon Feb 14 16:47:58 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064946, encodeId=37c91064946f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dd32880781, createdName=jy21354, createdTime=Fri Oct 29 12:11:52 CST 2021, time=2021-10-29, status=1, ipAttribution=)]
    2022-03-09 145a16f4m24暂无昵称

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2141180, encodeId=c6842141180e0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75415234, createdName=ms6000000204662260, createdTime=Tue Jun 06 23:59:40 CST 2023, time=2023-06-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1201732, encodeId=bbe71201e3257, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed35625050, createdName=ms4000000919175717, createdTime=Fri Mar 11 16:26:59 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200829, encodeId=5cb3120082985, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/10/9c891de22a04ad3664335f140cf03e65.jpg, createdBy=98035075733, createdName=145a16f4m24暂无昵称, createdTime=Wed Mar 09 10:18:04 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193337, encodeId=2b3b119333e10, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b55675ktMWicxZps0b0Tt21jZhnAsy86ntv7Od1ldhicQL19tWMG4xq1EicYN1jBKhe73qYKib6aQkrFsL3pEZFASw/132, createdBy=50e92381638, createdName=Aling 陶宇满玲, createdTime=Mon Feb 14 16:47:58 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064946, encodeId=37c91064946f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dd32880781, createdName=jy21354, createdTime=Fri Oct 29 12:11:52 CST 2021, time=2021-10-29, status=1, ipAttribution=)]
    2022-02-14 Aling 陶宇满玲

    学习啦

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2141180, encodeId=c6842141180e0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75415234, createdName=ms6000000204662260, createdTime=Tue Jun 06 23:59:40 CST 2023, time=2023-06-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1201732, encodeId=bbe71201e3257, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed35625050, createdName=ms4000000919175717, createdTime=Fri Mar 11 16:26:59 CST 2022, time=2022-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200829, encodeId=5cb3120082985, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/10/9c891de22a04ad3664335f140cf03e65.jpg, createdBy=98035075733, createdName=145a16f4m24暂无昵称, createdTime=Wed Mar 09 10:18:04 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193337, encodeId=2b3b119333e10, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b55675ktMWicxZps0b0Tt21jZhnAsy86ntv7Od1ldhicQL19tWMG4xq1EicYN1jBKhe73qYKib6aQkrFsL3pEZFASw/132, createdBy=50e92381638, createdName=Aling 陶宇满玲, createdTime=Mon Feb 14 16:47:58 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064946, encodeId=37c91064946f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dd32880781, createdName=jy21354, createdTime=Fri Oct 29 12:11:52 CST 2021, time=2021-10-29, status=1, ipAttribution=)]
    2021-10-29 jy21354

    学习了

    0